Literature DB >> 23205377

Drug safety awareness in New Zealand: public knowledge and preferred sources for information.

Fredrik Brounéus1, Greg Macleod, Karyn Maclennan, Lianne Parkin, Charlotte Paul.   

Abstract

INTRODUCTION: To make informed choices about medical treatment options, patients and consumers need knowledge about the benefits and the risks of drugs. Little is known about levels of drug safety knowledge or preferred sources of drug safety information in general population samples. AIM: To explore drug safety knowledge, experience of adverse drug reactions (ADRs), and preferred sources for drug safety information in the New Zealand public.
METHODS: We undertook a telephone survey of a random sample of adults (N=87) in the Dunedin area of New Zealand.
RESULTS: Although 47% of those currently or recently using prescription or over-the-counter drugs (N=83) were unable to recall any safety information at all about the medicine they were taking, 84% felt confident they could use these medicines in a safe way. The experience of at least one ADR during the last five years was reported by 40%. The five most preferred sources for drug safety information among all participants were: doctor (92%), pharmacist (76%), information on/inside the medicine package (66%), nurse (57%), and the internet (41%). DISCUSSION: Our results add to findings from specific patient groups to show that there is a low level of drug safety knowledge in the general population. Primary health care practitioners have a recognised and vital part to play in promoting drug safety awareness.

Entities:  

Mesh:

Year:  2012        PMID: 23205377

Source DB:  PubMed          Journal:  J Prim Health Care        ISSN: 1172-6156


  7 in total

1.  Trends in exposure to televised prescription drug advertising, 2003-2011.

Authors:  Rachel Kornfield; G Caleb Alexander; Dima M Qato; Yoonsang Kim; Jan D Hirsch; Sherry L Emery
Journal:  Am J Prev Med       Date:  2015-05       Impact factor: 5.043

2.  Knowledge, Beliefs and Behaviours Regarding the Adverse Effects of Medicines in an Omani Population: Cross-sectional survey.

Authors:  Jimmy Jose; Beena Jimmy; Moza N S Al-Mamari; Thuraiya S N Al-Hadrami; Halima M Al-Zadjali
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

3.  Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR: a cross-sectional study for public health improvement in low and middle income countries.

Authors:  Céline Caillet; Chanvilay Sichanh; Lamphone Syhakhang; Cyrille Delpierre; Chanthanom Manithip; Mayfong Mayxay; Maryse Lapeyre-Mestre; Paul N Newton; Anne Roussin
Journal:  BMC Public Health       Date:  2015-06-27       Impact factor: 3.295

4.  General Public Views, Attitudes, and Experiences toward Drug Safety in Dubai, United Arab Emirates: A Qualitative Approach.

Authors:  Doaa Alkhalidi; Shazia Qasim Jamshed; Ramadan Mohamed Elkalmi; Mirza Rafi Baig; Adeel Aslam; Mohamed Azmi Hassali
Journal:  Pharmacy (Basel)       Date:  2019-02-07

5.  The views of New Zealand general practitioners and patients on a proposed risk assessment and communication tool: a qualitative study using Normalisation Process Theory.

Authors:  Sharon Leitch; Alesha Smith; Sue Crengle; Tim Stokes
Journal:  Implement Sci Commun       Date:  2021-02-10

6.  Knowledge, attitudes, and practices towards drug-food interactions among patients at public hospitals in eThekwini, KwaZulu-Natal, South Africa.

Authors:  Emmanuella C Osuala; Boikhutso Tlou; Elizabeth B Ojewole
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

7.  Users' Knowledge About Adverse Effects of Non-steroidal Anti-inflammatory Drugs in Tirana, Albania.

Authors:  Dajana Roshi; Ervin Toçi; Genc Burazeri; Peter Schröder-Bäck; Ledjan Malaj; Helmut Brand
Journal:  Mater Sociomed       Date:  2017-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.